Once daily tacrolimus

Astellas has launched Advagraf (tacrolimus), indicated for the prophylaxis of transplant rejection in kidney or liver allograft recipients and treatment of allograft rejection resistant to other immunosuppressants.

Advagraf is available as 0.5mg, 1mg and 5mg sustained-release capsules in a pack size of  28 capsules.

Further information: Astellas 01784 419615.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more